SMI 8'646 0.3%  Dow 16'194 0.9%  Nikkei 18'095 -0.4%  Euro 1.0888 0.4% 
SPI 8'812 0.3%  EStoxx50 3'209 0.6%  Gold 1'134 -0.5%  Dollar 0.9694 1.1% 
DAX 10'068 0.5%  FTSE100 6'097 0.6%  Öl 49.0 -0.6%  Pfund 1.4830 1.0% 

Biomarin Pharmaceutical Aktie [Valor: 729021 / ISIN: US09061G1013]

Analysen zu Biomarin Pharmaceutical Inc.

08.07.15 Biomarin Pharmaceutical Outperform RBC Capital Markets
19.06.15 Biomarin Pharmaceutical Neutral Robert W. Baird & Co. Incorporated
18.06.15 Biomarin Pharmaceutical Buy Deutsche Bank AG
18.06.15 Biomarin Pharmaceutical Buy Canaccord Adams
18.06.15 Biomarin Pharmaceutical Outperform RBC Capital Markets
05.06.15 Biomarin Pharmaceutical overweight Barclays Capital
27.03.15 Biomarin Pharmaceutical Buy UBS AG
27.03.15 Biomarin Pharmaceutical Buy Deutsche Bank AG
19.12.14 Biomarin Pharmaceutical Outperform RBC Capital Markets
11.12.14 Biomarin Pharmaceutical Buy UBS AG
25.11.14 Biomarin Pharmaceutical Outperform RBC Capital Markets
24.10.14 Biomarin Pharmaceutical Outperform RBC Capital Markets
06.11.12 Biomarin Pharmaceutical outperform RBC Capital Markets
03.09.12 Biomarin Pharmaceutical outperform RBC Capital Markets
28.08.12 Biomarin Pharmaceutical hold Deutsche Bank Securities
23.07.12 Biomarin Pharmaceutical outperform RBC Capital Markets
22.06.12 Biomarin Pharmaceutical outperform RBC Capital Markets
01.06.12 Biomarin Pharmaceutical outperform RBC Capital Markets
17.02.12 Biomarin Pharmaceutical outperform RBC Capital Markets
13.02.12 Biomarin Pharmaceutical outperform RBC Capital Markets
12.12.11 Biomarin Pharmaceutical buy Citigroup Corp.
08.12.11 Biomarin Pharmaceutical buy Citigroup Corp.
07.12.11 Biomarin Pharmaceutical buy Jefferies & Company Inc.
29.09.11 Biomarin Pharmaceutical buy Deutsche Bank Securities
25.10.10 Biomarin Pharmaceutical neutral Wedbush Morgan Securities Inc.
17.08.10 Biomarin Pharmaceutical neutral Wedbush Morgan Securities Inc.
16.04.10 Biomarin Pharmaceutical kaufen Der Aktionär
29.10.09 Biomarin Pharmaceutical outperform Credit Suisse Group
22.10.09 Biomarin Pharmaceutical buy Citigroup Corp.
19.10.09 Biomarin Pharmaceutical hold ROTH Capital Partners, LLC
08.10.09 Biomarin Pharmaceutical buy Jefferies & Company Inc.
03.08.09 Biomarin Pharmaceutical neutral Wedbush Morgan Securities Inc.
31.07.09 Biomarin Pharmaceutical buy Jefferies & Company Inc.
27.07.09 Biomarin Pharmaceutical buy ROTH Capital Partners, LLC
31.03.09 Biomarin Pharmaceutical market weight Thomas Weisel Partners LLC
27.03.09 Biomarin Pharmaceutical neutral Piper Jaffray & Co.
12.03.09 Biomarin Pharmaceutical outperform Leerink Swann LLC
12.03.09 Biomarin Pharmaceutical buy FTN Midwest Securities Corp.
24.02.09 Biomarin Pharmaceutical buy ROTH Capital Partners, LLC
23.02.09 Biomarin Pharmaceutical buy Jefferies & Company Inc.
19.02.09 Biomarin Pharmaceutical neutral Credit Suisse Group
19.02.09 Biomarin Pharmaceutical market perform Wachovia Securities, LLC
19.02.09 Biomarin Pharmaceutical hold ROTH Capital Partners, LLC
19.02.09 Biomarin Pharmaceutical buy Brean Murray, Carret & Co., LLC
09.01.09 Biomarin Pharmaceutical buy Brean Murray, Carret & Co., LLC
15.12.08 Biomarin Pharmaceutical neutral Credit Suisse Group
26.11.08 Biomarin Pharmaceutical outperform Cowen and Company, LLC
24.11.08 Biomarin Pharmaceutical buy Citigroup Corp.
30.10.08 Biomarin Pharmaceutical neutral Credit Suisse Group
30.10.08 Biomarin Pharmaceutical buy UBS AG
Seite: 1 | 2

Anmeldung notwendig

Benutzername (E-Mail):
Passwort:
 
Anmelden
 

Um diese Funktionalität nutzen zu können, müssen Sie sich anmelden.
Falls Sie noch kein Benutzerkonto bei finanzen.ch besitzen, können Sie sich hier kostenlos registrieren.

Eintrag hinzufügen

Aktuelle Aktienanalysen
16:32 Cincinnati Financial Buy MKM Partners
16:05 Third Point Reinsurance Buy Compass Point
15:23 Press Ganey Buy Canaccord Adams
14:59 Exa Buy Canaccord Adams
14:55 Adobe Systems Perform Oppenheimer & Co. Inc.
14:54 Aerovironment Hold Canaccord Adams
14:25 Ambarella Buy Ascendiant Capital Markets
14:24 Ambarella Buy Canaccord Adams
14:12 KWS SAAT Halten Bankhaus Lampe KG
14:08 BHP Billiton Hold Deutsche Bank AG
14:08 Evotec kaufen Bankhaus Lampe KG
14:05 KWS SAAT Hold Warburg Research
13:59 Zurich Insurance Group Halten Bankhaus Lampe KG
13:40 PayPal Buy Argus Research Company
13:27 Recro Pharma Buy H.C. Wainwright & Co.
13:23 AcelRx Pharmaceuticals Buy H.C. Wainwright & Co.
13:10 TOTAL Halten Independent Research GmbH
12:59 Ambarella Buy Topeka Capital Markets
12:56 BNP Paribas overweight Morgan Stanley
12:56 BB&T Outperform Robert W. Baird & Co. Incorporated
12:54 Barclays overweight Morgan Stanley
12:51 Standard Chartered Underweight Morgan Stanley
12:42 UBS Group overweight Morgan Stanley
12:41 Credit Suisse overweight Morgan Stanley
12:38 Matrix Service Buy Stifel, Nicolaus & Co., Inc.
12:35 Deutsche Bank Equal-Weight Morgan Stanley
12:23 Münchener Rückversicherungs-Gesellschaft Halten Bankhaus Lampe KG
12:18 Talanx kaufen Bankhaus Lampe KG
12:17 Assicurazioni Generali kaufen Bankhaus Lampe KG
12:15 AXA kaufen Bankhaus Lampe KG
12:04 Allianz kaufen Bankhaus Lampe KG
11:48 KWS SAAT Hold Hauck & Aufhäuser Privatbankiers KGaA
11:46 SAF-Holland SA buy Hauck & Aufhäuser Privatbankiers KGaA
11:36 Bertrandt buy Hauck & Aufhäuser Privatbankiers KGaA
11:27 American Airlines Group Outperform Imperial Capital
11:26 Deutsche Börse Neutral equinet AG
11:26 ABB Neutral JP Morgan Chase & Co.
11:25 Münchener Rückversicherungs-Gesellschaft overweight JP Morgan Chase & Co.
11:23 ARM Neutral JP Morgan Chase & Co.
11:18 Enova International Mkt Perform FBR Capital
11:18 Volkswagen vz kaufen Norddeutsche Landesbank (Nord/LB)
11:17 On Deck Capital Outperform FBR Capital
11:17 Springleaf Outperform FBR Capital
11:16 Richemont buy HSBC
11:14 AstraZeneca buy UBS AG
11:13 The Liberty Outperform FBR Capital
11:12 KWS SAAT Halten Norddeutsche Landesbank (Nord/LB)
11:11 AstraZeneca buy HSBC
11:02 Stroeer buy Hauck & Aufhäuser Privatbankiers KGaA
10:56 Wacker Chemie Hold Hauck & Aufhäuser Privatbankiers KGaA